Court Denies Novo's Attempt to Halt Lilly's Obesity Drug Advertisements | Retatrutide News

A court has rejected Novo Nordisk's bid to stop Eli Lilly from advertising its obesity drug. This decision affects the competitive landscape in GLP-1 ag...
Market News · October 27, 2026